Диссертация (1139753), страница 22
Текст из файла (страница 22)
Juvenile rheumatoid arthritis. J Pediatr 1946;29:143.57.Cron RQ, Gordon PV. Reactive arthritis to Clostridium difficile in a child. West JMed. 1997 Jun; 166(6):419-21.58.De Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, PrakkenBJ. Blood and synovial fluid cytokine signatures in patients with juvenileidiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589–98.59.Diamantberger M.S. Du Rhumatisme noueux (polyarthrite deformante) chez lesenfants.
These pour le doctoral en medicine. Paris: Lecrosnier et Babe, 1891.60.Edelsten C, Lee V, Bentley CR, Kanski JJ, Graham EM. An evaluation of baselinerisk factors predicting severity in juvenile idiopathic arthritis associated uveitis andother chronic anterior uveitis in early childhood.
Br J Ophthalmol. 2002;86(1):51–6.61.Edelsten C, Lee V, Bentley CR et al. An evaluation of baseline risk factorspredicting severity in juvenile idiopathic arthritis associated uveitis and otherchronic anterior uveitis in early childhood. Br J Ophthalmol 2002 Jan;86(1):51–56.62.European League Against Rheumatism: EULAR Bulletin №4: Nomenclature andClassification of Arthritis in Children. Basel: National Zeitung A.G.,1977.63.Firestein GS. Starving the synovium: angiogenesis and inflammation inrheumatoid arthritis.
J Clin Invest. 1999;103(1):3–4.64.Fleischmann R. Safety and efficacy of disease-modifying antirheumatic agents inrheumatoid arthritis and juvenile rheumatoid arthritis. Expert Opin Drug Saf. 2003Jul;2(4):347-65.13965.Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminarydefinition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202–9.66.Giannini EH, Ravelli A. et al. Definition of juvenile arthritis. Arthritis Rheum1996;35:102–9.67.Gilliam BE, Chauhan AK, Low JM, Moore TL. Measurement of biomarkers injuvenile idiopathic arthritis patients and their significant association with diseaseseverity: a comparative study.
Clin Exp Rheumatol. 2008; 26(3): 492-7.68.Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait.Arthritis Rheum. 1999;42:2261–2268.69.Guillaume S, Prieur AM, Coste J, Job-Deslandre C. Long-term outcome andprognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum.2000;43(8):1858–65.70.Hanova P, Pavelka K, Dostal et al.
Epidemiology of rheumatoig arthritis, juvenileidiopatic arthritis and gout in two regions of the Czech Republic in a descriptivepopulation based survey in 2002-2003. Clin Exp Rheumatol 2006; 24:499-507.71.Helmic C, Felson D, Lawrence R, et al. National Arthritis Data Workgroup:Estimates of the prevalence of arthritis and other rheumatic conditions in theUnited States Part 1. Arthritis Rheum. 2008; 58: 15-28.72.Henning Zeidler, Alan P Hudson.
Coinfection of Chlamydiae and other Bacteria inReactiveArthritisandSpondyloarthritis:NeedforFutureResearch.Microorganisms. 2016 Aug 24;4(3).73.Himanshu Pathak and Tarnya Marshall. Post-streptococcal reactive arthritis: whereare we now. BMJ Case Rep. 2016; 2016: bcr2016215552.74.Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, et al. Densegenotyping of immune-related disease regions identifies 14 new susceptibility locifor juvenile idiopathic arthritis. Nat Genet. 2013;45:664–669.75.Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E, et al. Overlap of diseasesusceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis.
AnnRheum Dis. 2010;69(6):1049-53.14076.Hoeve M, Kalinina Ayuso V, Schalij-Delfos NE, Los LI, Rothova A, de Boer JH.The clinical course of juvenile idiopathic arthritis-associated uveitis in childhoodand puberty. Br J Ophthalmol 2012 Jun;96(6):852–856.77.Hollenbach JA, et al. Juvenile idiopathic arthritis and HLA class I and class IIinteractions and age-at-onset effects. Arthritis Rheum. 2010;62(6):1781–179.78.Horneff G.
Update on biologicals for treatment of juvenile idiopathic arthritis.Expert Opin Biol Ther 2013;13:361–76.79.Huemer C, Malleson PN, Cabral DA, et al. Patterns of joint involvement at onsetdifferentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenilerheumatoid arthritis. J Rheumatol. 2002;29(7):1531–5.80.Hunter PJ, Nistala K.
et al. Biologic predictors of extension of oligoarticularjuvenile idiopathic arthritis as determined from synovial fluid cellular compositionare gene expression. Arthritis Rheum. 2010; 62(3): 896-907.81.Huygen A.C., Kuis W., Sinnema G. Psychological, behavioral and socialadjustment in children and adolescents with juvenile chronic arthritis //Ann.Rhem.Dis. – 2000. - V.59,№ 4.
- P. 276-282.82.John D Carter, Hervé C Gérard, Judith A Whittum-Hudson and Alan P Hudson.Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis:is a cure in sight? Int J Clin Rheumtol. 2011 Jun; 6(3): 333–345.83.Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunityand inflammatory disease. Nat Rev Immunol.
2013;13:321–335.84.Kesen MR, Setlur V, Goldstein DA. Juvenile idiopathic arthritis-related uveitis. IntOphthalmol Clin 2008 Summer;48(3):21–38.85.Kocharla L, Taylor J, Weiler T, Ting TV, Luggen M, Brunner HI. Monitoringmethotrexate toxicity in juvenile idiopathic arthritis. J Rheumatol 2009; 36: 2813–8.86.Kodsi SR, Rubin SE, Milojevic D, Ilowite N, Gottlieb B.
Time of onset of uveitisin children with juvenile rheumatoid arthritis. J AAPOS. 2002;6(6):373–6.87.Kotake S, Nanke Y. Chlamydia-associated arthritis and enteropathic arthritis - twoimportant spondyloarthritides. 2011;34(3):121-30.14188.Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M. Uveitis inyoung adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients.Ann Rheum Dis 2005 Jun;64(6):871–874.89.Kozeis N, Trachana M, Tyradellis S. Keratitis in reactive arthritis (Reitersyndrome) in childhood. Cornea. 2011 Aug;30(8):924-5.90.Kuon W, Sieper J. Identification of HLA-B27-restricted peptides in reactivearthritis and other spondyloarthropathies: computer algorithms and fluorescentactivated cell sorting analysis as tools for hunting of HLA-B27-restrictedchlamydial and autologous crossreactive peptides involved in reactive arthritis andankylosing spondylitis.
Rheum Dis Clin North Am. 2003 Aug;29(3):595-611.91.Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long termprognosis of reactive arthritis. Ann Rheum Dis. 2003 Jul; 62(7):655-8.92.Lahu A, Bajraktari IH, Lahu S, Saiti V, Kryeziu A, Sherifi F, Durmishi B. Thesource of infection and the most frequent causes of reactive arthritis in Кosovo.Mater Sociomed. 2016 Jun;28(3):201-4.93.Li CW, Ma JJ, Yin J, Liu L, Hu J. Reiter's syndrome in children: a clinical analysisof 22 cases. Zhonghua Er Ke Za Zhi. 2010 Mar;48(3):212-5.94.Lin YT, Wang CT, Gershwin ME, Chiang BL.
The pathogenesis ofoligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. AutoimmunRev. 2011;10(8):482–489.95.Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do weknow? Rheumatology (Oxford) 2004;43:949–54.96.Mangge H, Kenzian H, Gallistal S, et al. Serum cytokines in juvenile rheumatoidarthritis: correlation with conventional inflammation parameters and clinicalsubtypes. Arthritis Rheum 1995; 38:211-20.97.Maruotti N1, Corrado A, Cantatore FP. Osteoporosis and rheumatic diseases.Reumatismo. 2014 Jun 28;66(2):125-35.98.Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, Vierucci S,Brandi ML, Falcini F.
Osteoprotegerin (OPG)/RANK-L system in juvenile142idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in boneinjury? J Rheumatol. 2004 May; 31(5):986-91.99.Matthew L Stoll, Quan-Zhen Li, Jinchun Zhou, Marilynn Punaro, Nancy J Olsen.Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritismay predict a refractory course. Clin Exp Rheumatol. 2011 Jul-Aug; 29(4): 736–742.100. Michela Cappella, Fabrizio Pugliese, Andrea Zucchini, and Federico Marchetti.Сlostridium difficile Enterocolitis and Reactive Arthritis: A Case Report andReview of the Literature.
Case Rep Pediatr. 2016; 2016: 1591753.101. Miika Arvonen, Lillemor Berntson, Tytti Pokka et al. Gut microbiota-hostinteractions and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016; 14:44.102. Minden K, Niewerth M, Listing J, Biederman T, Bollow M, Schontube M, et al.Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum.2002; 46(9): 2392-401.103. Nistala K, et al.
Th17 plasticity in human autoimmune arthritis is driven by theinflammatory environment. Proc Natl Acad Sci U S A. 2010;107(33):14751–14756.104. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR.Interleukin-17-producing T cells are enriched in the joints of children witharthritis, but have a reciprocal relationship to regulatory T cell numbers. ArthritisRheum. 2008;58:875–887.105.
Nistala K, Wedderburn LR. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology. 2009;48(6):602–606.106. Oen K, Fast M, Postl B. Epidemiology of juvenile rheumatoid arthritis inManitoba, Canada, 1975-92: cycles in incidence. J Rheumatol. 1995 Apr;22(4):745-50.107. Ortiz-Alvarez O, Morishita K, Avery G, Green J, Petty RE, Tucker LB, et al.Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathicarthritis.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
